Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry
Jonathan M. Behar, Hui Men Selina Chin, Steve Fearn, Julian O.M. Ormerod, James Gamble, Paul W.X. Foley, Julian Bostock, Simon Claridge, Tom Jackson, Manav Sohal, Antonios P. Antoniadis, Reza Razavi, Tim R. Betts, Neil Herring and Christopher Aldo Rinaldi
Incremental Cost and Cost-Effectiveness of Implanting a Quadripolar Versus Bipolar CRT-D System, Varied by the Additional Acquisition Cost of the Quadripolar System
Quadripolar (quad) leads that cost up to £932 ($1,398) more than bipolar leads result in either a cost-neutral outcome or a cost saving because of reduced health-care utilization events. CRT-D = cardiac resynchronization defibrillator therapy device; ICER = incremental cost-effectiveness ratio.